Improving drug management for heart failure patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create an interactive AI-based multicenter database to enhance the quality of care for patients with heart failure (HF). It will collect detailed information on patient characteristics, treatment practices, adherence to guideline-based optimal drug therapy, and outcomes. The database is built on a registry that has been active for two years and will utilize an AI algorithm to assess whether patients are receiving appropriate treatment according to the latest European Society of Cardiology guidelines. The study seeks to identify levels of non-adherence to these guidelines and provide insights to reduce medical inertia and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Both gender
* Age \>18 years
* Signed informed consent for the study
* Known diagnosis of heart failure \> 6 months
* Recent or ongoing hospitalization for heart failure exacerbation

Exclusion Criteria:

* Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons
* Concurrent diagnosis of neoplasia
* Advanced COPD (FEV1 \<50%)
* Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)

Where it's running

• IRCCs San Raffaele
  Rome, Rm, Italy Recruiting

Study contacts

• Study coordinator: Lucia Gatta, PhD
• Email: lucia.gatta@sanraffaele.it
• Phone: +390652253440

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• NT-proBNP–guided heart failure screening for people 65+ in rural China

  This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.

  Recruiting Jiangsu Taizhou People's Hospital · Nanjing · NCT07885488

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.